Lungpacer Diaphragm Pacer Gets FDA Emergency Use Authorization for COVID-19
Lungpacer Medical, based in Vancouver, Canada, announced that its Diaphragm Pacing Therapy (DPT) System received FDA Emergency Use Authorization for use in weaning COVID-19 patients off of ventilators. Patients on prolonged mechanical ventilation may experience diaphragm disuse atrophy and ventilator-induced diaphragmatic dysfunction (VIDD), which makes it harder for patients to breathe on their own and […]
Read More